Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON.ARRANON® (nelarabine) injection, for intravenous useInitial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
ARRANON is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
- generic_name
- nelarabine
- product_names
- nelarabine
- ndc
- 0078-0683, 0078-0683-06, 0078-0683-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en